Eko Analysis Software vs Us2.ca

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Eko Analysis Software

by Eko Devices

Us2.ca

by Eko.Ai Pte Ltd. D/B/A Us2.Ai

AI Verdict

Eko Analysis Software focuses on early detection of cardiovascular diseases like heart murmurs and atrial fibrillation using digital stethoscopes and ECGs, making it suitable for initial screenings and remote monitoring. In contrast, Us2.ai specializes in fully automated analysis of echocardiography images, providing comprehensive diagnostic reports for a wider range of structural and functional cardiac conditions. While both are cardiology AI tools, they serve different points in the diagnostic pathway, with Eko leveraging auscultation and Us2.ai focusing on advanced imaging interpretation.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you are a clinician seeking an accessible, point-of-care tool for early cardiovascular disease screening, particularly for heart murmurs and atrial fibrillation, directly from auscultation. It's ideal for integrating AI-powered detection with a digital stethoscope for quick assessments, remote monitoring, and secure recording of heart sounds and ECGs in a primary care or emergency setting.

View Eko Analysis Software →

Choose Us2.ca if…

Choose Us2.ca if your cardiology or radiology department requires fully automated, comprehensive echocardiography analysis to streamline workflow and enhance diagnostic accuracy for complex cardiac conditions. This platform is best suited for high-volume imaging centers that need real-time processing, structured reporting, and seamless integration with existing PACS, CVIS, and EMR systems for advanced disease detection.

View Us2.ca →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Eko Analysis Software	Us2.ca
Pricing	Freemium with subscription for full features	Contact for pricing
Deployment	Cloud-based	Cloud, On-premise
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Eko Analysis Software	Us2.ca
Name	Eko Analysis Software	Us2.ca
Company	Eko Devices	Eko.Ai Pte Ltd. D/B/A Us2.Ai
Core AI Functionality	AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases.	AI platform that fully automates echocardiography analysis, delivering comprehensive, structured cardiac reports.
Specific Disease Detection	Heart murmur detection, Atrial fibrillation (AFib) detection, Detection of normal sinus rhythm	Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, Pulmonary Hypertension
Report Generation	PDF reports (with Eko+ membership)	Comprehensive, structured cardiac reports in seconds

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and Us2.ca.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in the type of cardiac data these tools analyze?

Eko Analysis Software is designed to analyze heart sounds and ECGs captured via Eko's digital stethoscopes and mobile app. In contrast, Us2.ai fully automates the analysis of echocardiography images, integrating with ultrasound devices, PACS, CVIS, and EMR systems.

What specific cardiovascular conditions do these AI tools assist in detecting?

Eko Analysis Software is FDA-cleared to assist clinicians in the early detection of heart murmurs and atrial fibrillation, and also identifies normal sinus rhythm. Us2.ai offers AI-powered disease detection for conditions such as Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, and Pulmonary Hypertension through automated echocardiography analysis.

How do these tools integrate into a physician's existing workflow and systems?

Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app for recording, playback, and secure cloud-based storage of heart sounds and ECGs. Us2.ai is designed to slot into existing infrastructure, integrating with ultrasound devices, PACS, CVIS, and EMR systems to process studies automatically and deliver structured reports.

What are the key outputs or reports generated by each tool?

Eko Analysis Software provides FDA-cleared AI for heart murmur and AFib detection, normal sinus rhythm identification, cardiac time interval calculations, and visualization of phonocardiograms and ECG tracings, with the ability to generate PDF reports. Us2.ai delivers comprehensive, structured cardiac reports in seconds through fully automated echocardiography analysis, including guideline-based measurements, disease indication conclusions, and comprehensive cardiac structural and functional parameters.

Which medical specialties are these tools primarily designed to support?

Eko Analysis Software is designed to support Cardiology, Emergency Medicine, and Internal Medicine, focusing on early detection through auscultation and ECG. Us2.ai primarily targets Cardiology and Radiology, specializing in advanced, automated analysis of echocardiography images.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Eko Analysis Software or Us2.ca

Backers

Who funded each tool's parent company.

Eko Analysis Software

Dreamit Ventures